Binge-Eating Disorder (BED) is an eating disorder where a person is compelled to eat large quantities of food over a short period of time even when the person is not hungry. This is done on a regular basis through regular binges.
Doctors at the Lindner Center of HOPE is studying the effectivity of the medication lisdexamfetamine dimesylate in decreasing the days patients with BED would binge eat, compared to a placebo. The medicine is currently being used for treating attention-deficit/hyperactivity disorder.
This is a significant discovery since to date, there is no approved medication for BED. It has been noted that Binge-Eating Disorder is associated symptoms of mental illness and obesity. Randomized clinical trials on the use of lisdexamfetamine dimesylate in treating BED have been conducted in 2011 to 2012 covering 500 patients with the eating disorder with positive results.
Ongoing clinical trials being conducted may lead to a safe and improved pharmacologic treatment for moderate to severe BED.
Doctors at the Lindner Center of HOPE is studying the effectivity of the medication lisdexamfetamine dimesylate in decreasing the days patients with BED would binge eat, compared to a placebo. The medicine is currently being used for treating attention-deficit/hyperactivity disorder.
This is a significant discovery since to date, there is no approved medication for BED. It has been noted that Binge-Eating Disorder is associated symptoms of mental illness and obesity. Randomized clinical trials on the use of lisdexamfetamine dimesylate in treating BED have been conducted in 2011 to 2012 covering 500 patients with the eating disorder with positive results.
Ongoing clinical trials being conducted may lead to a safe and improved pharmacologic treatment for moderate to severe BED.